Merck buys rights to heart disease drug in latest China deal worth up to $2 billion
On Mar. 25, 2025, Merck announced it has signed a licensing agreement for a heart disease drug with…
New Evidence Links Microplastics with Chronic Disease
On Mar. 25, 2025, research from the American College of Cardiology reported that tiny fragments of plastic have…
Alnylam Announces FDA Approval of AMVUTTRA® (vutrisiran), the First RNAi Therapeutic to Reduce Cardiovascular Death, Hospitalizations and Urgent Heart Failure Visits in Adults with ATTR Amyloidosis
On Mar. 20, 2025, Alnylam Pharmaceuticals announced the U.S. Food and Drug Administration (FDA) approval of the supplemental…
Australia’s first durable total artificial heart implant Reported successful
On Mar. 11, 2025, researchers at St Vincent’s Hospital Sydney announced the first implant of a BiVACOR Total…
Biotechnology | Diagnostics | Disease | Life Science News | Oncology | Therapeutics | Women's Health
More than half of adults and a third of children and adolescents predicted to have overweight or obesity by 2050
On Mar. 3, 2025, the Institute for Health Metrics and Evaluation reported that without urgent policy reform and…
World first procedure fixes lamb’s leaky heart
On Mar. 3, 2025, researchers from Oregon State University (OSU) announced the world’s first procedure successfully fixes lamb’s…
Biotechnology | Disease | FDA | Life Science News | Medicine | Neurology | Therapeutics
FDA Approves Genentech’s TNKase® in Acute Ischemic Stroke in Adults
On Mar. 3, 2025, Genentech announced that the U.S. Food and Drug Administration (FDA) has approved TNKase® (tenecteplase),…
‘Breakthrough’ stem-cell patches strengthened a woman’s failing heart
On Jan. 29, 2025, researchers from the University Medical Center Göttingen announced they have shown that patches of…
FDA approves Ozempic® (semaglutide) as only GLP-1 RA to reduce the risk of worsening kidney disease and cardiovascular death in adults with type 2 diabetes and CKD
On Jan. 28, 2025, Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) has approved Ozempic® to…
Biotechnology | Disease | Life Science News | Medical Device | Non-Profit Research | Organ Transplant | Therapeutics
BiVACOR Total Artificial Heart Successfully Implanted in Five Patients as Part of FDA Early Feasibility Study; FDA Greenlights Expansion of the EFS
On Dec. 18, 2024, BiVACOR, a clinical-stage medical device company, announced the successful completion of the first phase…
Biotechnology | COVID-19 | Disease | Infectious Disease | Influenza | Life Science News | Therapeutics
COVID-19 linked to more heart complications than flu, RSV
On Dec. 16, 2024, a study published in BMC Cardiovascular Disorders shows that pediatric and young adult COVID-19…
Risk of depression and heart disease linked in women
On Dec. 5, 2024, researchers Dr Sonia Shah and Dr Clara Jiang from the University of Queensland’s Institute…
State cancer agency awarded $89 million in grants to Texas institutions and companiesÂ
On Nov. 20, 2024, the Cancer Prevention and Research Institute of Texas (CPRIT) announced that it had approved…
Common arm positions can substantially overestimate blood pressure readings, Johns Hopkins study finds
On Oct. 9, 2024, a study led by Johns Hopkins Medicine researchers concluded that commonly used ways of…
Biotechnology | Disease | Life Science News | Medical Device | Non-Profit Research | Organ Transplant | Therapeutics
Successful first-in-human implantation of the BiVACOR Total Artificial Heart by Baylor and THI doctors
On Jul. 25, 2024, doctors from the Texas Heart Institute (THI), BiVACOR®, Baylor St. Luke’s Medical Center and…
CIRM awarded $26 million to advance clinical research across cancer, heart conditions, and rare diseases
On Jun. 28, 2024, the California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated…
Biotechnology | Diagnostics | Disease | Life Science News | Oncology | Therapeutics | WHO
Nearly 1.8 billion adults at risk of disease from not doing enough physical activity
On Jun. 26. 2024, the World Health Organization reported that new data show that nearly one third (31%)…
How a few days in space can disrupt a person’s biology
On Jun. 12, 2024, scientists at Weill Cornell Medicine in New York City reported that just a few…
Scientists discovered over 100 new genomic regions linked to blood pressure
On Apr. 30, 2024, National Institutes of Health (NIH) researchers and collaborators announced they had discovered over 100…
Wegovy received FDA approval for cardiovascular risk reduction in adults with known heart disease or obesity
On Mar. 8, 2024, the U.S. Food and Drug Administration approved a new indication for use of Novo…
Aspirin can help prevent a second heart attack, but most don’t take it
On Aug. 22, 2023, a study led by researchers at Washington University School of Medicine in St. Louis…
Biotechnology | COVID-19 | Diagnostics | Disease | Life Science News | NIH | Therapeutics
NIH-funded study showed blood pressure levels rose during pandemic
On Nov. 1, 2022, the National Institutes of Health (NIH) announced that adults with hypertension saw a small,…
Biotechnology | Diagnostics | Disease | Life Science News | Oncology | Radiology | Therapeutics | Women's Health
Major study linked breast cancer treatment with increased risk of cardiovascular disease
On Apr. 6, 2022, a new study in the Journal of Clinical Oncology showed that women receiving certain…
Biotechnology | Diagnostics | Disease | Genomics | Life Science News | Pharmaceutical | Therapeutics
Diverse genome sequences provided a powerful tool for studying risk of heart disease
On Dec. 8, 2021, in a large-scale study of people from diverse ancestries, researchers narrowed down the number…
New genetic test for heart-attack risk launched for patients at Mass General
On Jan. 27, 2021, researchers at the Broad Institute of MIT and Harvard, and Massachusetts General Hospital’s Center…
FDA approved Aurinia Pharmaceuticals LUPKYNIS (voclosporin) for adults with active lupus nephritis
On Jan. 22, 2021, Aurinia Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA)Â had approved LUPKYNISTM…
Biotechnology | Disease | Infectious Disease | Influenza | Life Science News | Therapeutics | Vaccine
High-dose influenza vaccine showed no additional benefit for heart disease patients
On Dec. 4, 2020, it was reported in JAMA that high-dose influenza (commonly known as flu) vaccines are…
Aspirin use best for those with high coronary calcium, low risk of bleeding
On Oct. 28, 2020, University of Texas (UT) Southwestern scientists reported that an X-ray test commonly used to…
Hydroxychloroquine showed no benefit in COVID-19 prevention
On Sept. 30, 2020, researchers from the Perelman School of Medicine at the University of Pennsylvania reported results…
Largest global study on hydroxychloroquine safety finds increased cardiovascular risk with azithromycin
On Aug. 24, 2020, the combination of hydroxychloroquine and azithromycin has been linked to significant cardiovascular risks, including…